Full Press Release Details
WARREN, N.J.,Feb. 5, 2026/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the company will host a webcast conference call to report its fourth quarter and full year 2025 financial results and provide an update on the company's business and outlook on Thursday, Feb. 19, 2026, at 4:30 p.m. ET.
To access the call by phone, pleaseclick hereto register and you will be provided with dial-in details. The webcast conference call can be accessed on the Investors section of the PTC website athttps://ir.ptcbio.com/events-presentations. A replay of the call will be archived on the company's website for 30 days.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. To learn more about PTC, please visit us atwww.ptcbio.comand follow us on LinkedIn, X, Facebook, and Instagram.